Issued Patents All Time
Showing 26–36 of 36 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10882848 | 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds | Martin Duplessis, Georg Jaeschke, Bernd Kuhn, Kiel Lazarski, Yvonne Alice Nagel +3 more | 2021-01-05 |
| 10870651 | Inhibitors of cyclin-dependent kinase 7 (CDK7) | Nathanael S. Gray, Tinghu Zhang, Nicholas Paul Kwiatkowski | 2020-12-22 |
| 10865204 | Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use | Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Nicholas Paul Kwiatkowski, Baishan Jiang +1 more | 2020-12-15 |
| 10865205 | Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use | Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Nicholas Paul Kwiatkowski | 2020-12-15 |
| 10849982 | C3-carbon linked glutarimide degronimers for target protein degradation | Andrew J. Phillips, Chris G. Nasveschuk, James A. Henderson, Minsheng He, Kiel Lazarski +2 more | 2020-12-01 |
| 10660968 | Spirocyclic degronimers for target protein degradation | Andrew J. Phillips, Chris G. Nasveschuk, James A. Henderson, Kiel Lazarski, Ryan E. Michael | 2020-05-26 |
| 10646575 | Heterocyclic degronimers for target protein degradation | Andrew J. Phillips, Chris G. Nasveschuk, James A. Henderson, Mark Fitzgerald, Minsheng He +1 more | 2020-05-12 |
| 10532103 | Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of use | Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Nicholas Paul Kwiatkowski | 2020-01-14 |
| 10457691 | Macrocyclic kinase inhibitors and uses thereof | Nathanael S. Gray, Hwan Geun Choi | 2019-10-29 |
| 10287268 | Imidazolyl kinase inhibitors and uses thereof | Nathanael S. Gray, Hwan Geun Choi | 2019-05-14 |
| 10265321 | Uses of salt-inducible kinase (SIK) inhibitors | Alykhan Shamji, Thomas Sundberg, Nathanael S. Gray, Ramnik Xavier, Stuart L. Schreiber +1 more | 2019-04-23 |